KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Progyny (PGNY) Payables (2018 - 2025)

Historic Payables for Progyny (PGNY) over the last 8 years, with Q3 2025 value amounting to $123.1 million.

  • Progyny's Payables fell 565.22% to $123.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $123.1 million, marking a year-over-year decrease of 565.22%. This contributed to the annual value of $95.1 million for FY2024, which is 2418.08% down from last year.
  • Latest data reveals that Progyny reported Payables of $123.1 million as of Q3 2025, which was down 565.22% from $140.5 million recorded in Q2 2025.
  • Over the past 5 years, Progyny's Payables peaked at $151.7 million during Q2 2024, and registered a low of $54.7 million during Q2 2021.
  • Over the past 5 years, Progyny's median Payables value was $123.1 million (recorded in 2025), while the average stood at $108.9 million.
  • As far as peak fluctuations go, Progyny's Payables surged by 8793.5% in 2022, and later tumbled by 2418.08% in 2024.
  • Progyny's Payables (Quarter) stood at $61.4 million in 2021, then surged by 77.99% to $109.3 million in 2022, then increased by 14.77% to $125.4 million in 2023, then decreased by 24.18% to $95.1 million in 2024, then rose by 29.44% to $123.1 million in 2025.
  • Its Payables was $123.1 million in Q3 2025, compared to $140.5 million in Q2 2025 and $145.7 million in Q1 2025.